In general, when an anticancer agent could induce apoptosis in cancer cells, a decrease in the levels of anti‐apoptotic Bcl‐2 proteins and an increase in the levels of pro‐apoptotic protein (Bax) are observed (Skommer et al. 2010). The gene discussed is BCL2; the disease is cancer.